Controversies in management: Should methionine be added to every paracetamol tablet?: No: The risks are not well enough known

BMJ

Volumn 315, Issue 7103, 1997, Pages 301-

  Jones, A L ^a   Hayes, P C ^a   Vale, J A ^b   Prescott, L F ^c  

^a NHS LOTHIAN   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

METHIONINE; PARACETAMOL; ANALGESIC AGENT; ANTIDOTE;

DRUG FORMULATION; DRUG MIXTURE; DRUG OVERDOSE; HEALTH CARE COST; LIVER FAILURE; MORBIDITY; PRIORITY JOURNAL; RISK; SHORT SURVEY; ARTICLE; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG COST; ECONOMICS; HUMAN; INTOXICATION; LIVER DISEASE; MORTALITY;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANTIDOTES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COSTS; HUMANS; LIVER DISEASES; METHIONINE; OVERDOSE;

EID: 0031549222     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.315.7103.301     Document Type: Article

References (31)

1. Hawton K, Fagg J. Trends in deliberate self poisoning and self injury in Oxford, 1976-90. BMJ 1992; 304: 1409–11.
2. Litovitz TL, Felberg L, Soloway RA, Ford M, Geller R. 1995 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 1995; 13: 551–97.
3. McLean AEM. Prevention of paracetamol poisoning. Lancet 1974; i: 729.
4. Vale JA, Buckley BM, Meredith TJ. Deaths from paracetamol and dextropropoxyphene (distalgesic) poisoning in England and Wales Hum Toxicol 1984; 3: 135–43S.
5. Spooner JB, Harvey JG. Paracetamol overdosage—facts not misconceptions. Pharm J 1993; 250: 706–7.
6. Bond GR, Novak JE. The human and economic cost of paracetamol (acetaminophen) overdose. Pharmaco Economics 1995; 8: 177–81.
7. Maclean AEM, Day PA. The effect of diet on the toxicity of paracetamol and the safety of paracetamol-methionine mixtures. Biochem Pharamacol 1975; 24: 37–42.
8. Skoglund LA, Ingebrigtsen K, Lausund P, Nafstad I. Plasma concentration of paracetamol and its major metabolites after p o dosing with paracetamol or concurrent administration of paracetamol and its N-acetyl- DL-methionine ester in mice. Gen Pharmacol 1992; 23: 155–8.
9. Crome P, Volans GN, Goulding R, Vale JA, Widdop B. Oral methionine in the treatment of severe paracetamol (acetaminophen) overdose. Lancet 1976;ii:829–30.
10. Hamlyn AN, Lesna M, Record CO, Smith PA, Watson AJ, Meredith T, et al. Methionine and cysteamine in paracetamol (acetaminophen) overdose, prospective controlled trial of early therapy. J Int Med Res 1981; 9: 226–31.
11. Prescott LF, Park J, Sutherland GR, Smith IJ, Proudfoot AT. Cysteamine, methionine, and penicillamine in the treatment of paracetamol poisoning. Lancet 1976; ii: 109–13.
12. Vale JA, Meredith TJ, Goulding R. Treatment of acetaminophen poisoning. The use of oral methionine. Arch Intern Med 1981; 141: 394–6.
13. Zezulka AY, Calloway DH. Nitrogen retention in men fed isolated soybean protein supplemented with L-methionine, D-Methionine, N-acetyl- L-methionine, or inorganic sulfate. J Nutr 1976; 106: 1286–91.
14. Printen KJ, Brummel MC, Cho ES, Stegink LD. Utilization of D-Methionine during total parenteral nutrition in postsurgical patients. Am J Clin Nutr 1979; 32: 1200–5.
15. Cho ES, Stegink LD. D-Methionine utilization during parenteral nutrition in adult rats. J Nutr 1979; 109: 1086–93.
16. Connor H, Newton DJ, Preston FE, Woods HF. Oral methionine loading as a cause of acute serum folate deficiency: its relevance to parenteral nutrition. Postgrad Med J 1978; 54: 318–20.
17. Lemann J, Relman AS. Relation of sulfur metabolism to acid-base balance and electrolyte excretion effects of DL-methionine in normal man. J Clin Inv 1959; 38: 2215–23.
18. Cohen SM, Nichols A, Wyatt R, Pollin W. The administration of methionine to chronic schizophrenic patients: a review of ten studies. Biol Psychiatr 1974; 8: 209–25.
19. Phear EA, Ruebner B, Sherlock S, Summerskill WHJ. Methionine toxicity in liver disease and its prevention by chlortetracycline. Clin Sci 1956; 15: 93–7.
20. Gatton-Umpress TL, Weber KA, Seidler NW. Methionine metabolism: a window on carcinogenesis. Hosp Pract 1993; 28: 83–90.
21. Guo H, Lishko VK, Herrera H, Groce A, Kubota T, Hoffman RM. Therapeutic tumor-specific cell cycle block induced by methionine starvation in vivo. Cancer Res 1993; 53: 5676–9.
22. Breillot F, Hadida F, Echinard-Darin P, Lascaux V, Poupon MF. Decreased rat rhabdomyosarcoma pulmonary metastases in response to low methionine diet. Anticancer Res 1986; 76: 629–39.
23. Ueland PM, Refsum H, Brattstroem L. Plasma homocysteine and cardiovascular disease. In: Francis DB Jr, ed. Atherosclerotic cardiovascular disease, hemostasis and endothelial function. New York: Marcel Dekker, 1992: 1832–6.
24. Arnesen E, Refsum H, Bonaa KH, Ueland PM, Forde OH, Nordrehaug JE. The Tromso study: a population based prospective study of serum total homocysteine and coronary heart disease. Int J Epidemiol 1995; 24: 704–9.
25. Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Sahper AG. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995; 346: 1395–8.
26. Stampfer MJ, Malinow MR. Can lowering homocysteine levels reduce cardiovascular risk? N Engl J Med 1995; 332: 328–9.
27. Murph-Chutorian DR, Wexman MP, Greico AJ, Heininger JA, Glassman E, Gaull GE, et al. Methionine intolerance: a possible risk factor for coronary artery disease. J Am Coll Cardiol 1985; 6: 725–30.
28. Harker LA, Slichter SL, Scott CR, Ross R. Homocystinemia: vascular injury and arterial thrombosis. N Engl J Med 1974; 291: 537–43.
29. Stamler JS, Osborne JA, Jaraki O, Rabbin LE, Mullins M, Single D, et al. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 1993; 91: 308–18.
30. Tai J, Paralowie MA, Yoshizumi M, Hsieh CM, Haber E, Schlegal R, et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA 1994; 91: 6369–73.
31. Matthias D, Becker CH, Riezler R, Kindling PH. Homocysteine induced arteriosclerosis-like alterations of the aorta in normotensive and hypertensive rats following application of high doses of methionine. Atherosclerosis 1996; 122: 201–16.